Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 June 2021 | Story Legopheng Maphile | Photo Charl Devenish
Nthabiseng Kotsokoane in front of the Sasol Library on the Bloemfontein Campus of the University of the Free State. She is wearing a pink blouse with floral patterns and leaning with her left elbow against a ledge whilst looking into the camera.
Nthabiseng Kotsokoane is a renowned library professional whose passionate efforts to advance library and information services in Africa and beyond are widely acknowledged Photo: Charl Devenish

The University of the Free State is proud to announce the appointment of Nthabiseng Kotsokoane as chairperson of the International Federation of Library Associations and Institutions (IFLA) new Regional Council and member of the IFLA Governing Board 2021 – 2023.

IFLA is the leading international body representing the interests of library and information services and their users. It is the global voice of the library and information profession.

Nthabiseng Kotsokoane is currently the Assistant Director at the University of the Free State Library Information Services. She previously worked at Monash University for 10 years as a director of the library services. Ms Kotsokoane is a renowned library professional whose passionate efforts to advance library and information services in Africa and beyond are widely acknowledged. She has vast experience in serving at various committees regionally and internationally. She served as a member of the IFLA women information Libraries Special Interest Group. She was later elected by LIASA into the IFLA IT committee. She is the current IFLA Africa section Chair 2017-2021.

 

Serving the international library community

Nthabiseng is not only active in IFLA but on the African continent as well, she is the past chair for the African Library & Information Associations & Institutions (AfLIA) academic library section Chair and a member of the AfLIA Governing Board.

As IFLA’s Regional Chair her key role will be to in increase the presence of world regions in IFLA and IFLA’s presence around the world focusing on advocacy and building capacity. She will lead efforts to provide input on IFLA advocacy work and review success in developing the regional dimension of the IFLA Strategy, as well as work to promote IFLA membership and fundraising in the regions.

This will include coordination and development of Regional Division action plans, review Regional Division activities in the following regions Regional Council and Regional Divisions for Asia and Oceania, Europe, Latin America and the Caribbean, Middle East and North Africa, North America and Sub-Saharan Africa. With her passion of developing and mentoring new library professionals we are certain that this new role will be of benefit to the international library community.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept